UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 12b-25
NOTIFICATION OF LATE FILING
SEC FILE NUMBER: 0-10783
CUSIP NUMBER: 055662100
(Check One): [ ] Form 10-K [ ] Form 20-F
[ ] Form 11-K [X] Form 10-Q [ ] Form N-SAR
For Period Ended: November 30, 1998
[ ] Transition Report on Form 10-K
[ ] Transition Report on Form 20-F
[ ] Transition Report on Form 11-K
[ ] Transition Report on Form 10-Q
[ ] Transition Report on Form N-SAR
For the Transition Period Ended: _____________________
____________________________________________________________
PART I - REGISTRANT INFORMATION
____________________________________________________________
Full Name of Registrant: BSD Medical Corporation
Former Name if Applicable: N/A
Address of Principal Executive Office: 2188 West 2200 South
City, State and Zip Code: Salt Lake City, UT 84119
____________________________________________________________
PART II - RULES 12b-25(b) AND (c)
____________________________________________________________
If the subject report could not be filed without
unreasonable effort or expense and the registrant seeks
relief pursuant to Rule 12b-25(b), the following should be
completed. (Check box if appropriate)
[_] (a)The reasons described in reasonable detail
in Part III of this form could not be
eliminated without unreasonable effort or
expense;
[X] (b)The subject annual report, semi-annual
report, transition report on Form 10-K, Form
20-F, 11-K or Form N-SAR, or portion
thereof, will be filed on or before the
fifteenth calendar day following the
prescribed due date; or the subject
quarterly report or transition report on
Form 10-Q, or portion thereof will be filed
on or before the fifth calendar day
following the prescribed due date; and
[_] (c)The accountant's statement or other exhibit
required by Rule 12b-25(c) has been attached
if applicable.
____________________________________________________________
PART III - NARRATIVE
____________________________________________________________
State below in reasonable detail the reasons why the Form 10-
K, 20-F, 11-K, 10-Q, N-SAR, or the transition report or
portion thereof, could not be filed within the prescribed
time period.
Company representatives were unable to assemble the
materials necessary for a complete filing in a timely
manner.
____________________________________________________________
PART IV - OTHER INFORMATION
____________________________________________________________
(1)Name and telephone number of person to contact in regard
to this notification:
Dixie Toolson Sells 801 972-5555
(Name) (Area Code) (Telephone Number)
(2)Have all other periodic reports required under Section
13 or 15(d) of the Securities Exchange Act of 1934 or
Section 30 of the Investment Company Act of 1940 during
the preceding 12 months or for such shorter period that
the registrant was required to file such report(s) been
filed? If answer is no, identify report(s).
[X] Yes [_] No
(3)Is it anticipated that any significant change in results
of operations from the corresponding period for the last
fiscal year will be reflected by the earnings statements
to be included in the subject report or portion thereof?
[_] Yes [X] No
If so, attach an explanation of the anticipated change,
both narratively and quantitatively, and, if
appropriate, state the reasons why a reasonable estimate
of the results cannot be made.
BSD MEDICAL CORPORATION
__________________________________
(Name of Registrant as Specified in Charter)
has caused this notification to be signed on its behalf by
the undersigned thereunto duly authorized.
Date: January 13, 1999 By: /s/ Dixie Toolson Sells
Vice President, Regulatory Affairs
Corporate Secretary
INSTRUCTION: The form may be signed by an executive officer
of the registrant or by any other duly authorized
representative. The name and title of the person signing
the form shall be typed or printed beneath the signature.
If the statement is signed on behalf of the registrant by an
authorized representative (other than an executive officer),
evidence of the representative's authority to sign on behalf
of the registrant shall be filed with the form.
____________________________________________________________
ATTENTION
Intentional misstatements or omissions of fact constitute
Federal Criminal Violations (see 18 U.S.C. 1001).
____________________________________________________________
GENERAL INSTRUCTIONS
1.This Form is required by Rule 12b-25 (17 CFR 240.12b-25)
of the General Rules and Regulations under the Securities
and Exchange Act of 1934.
2.One signed original and four conformed copies of this
Form and amendments thereto must be completed and filed
with the Securities and Exchange Commission, Washington,
D.C. 20549, in accordance with Rule 0-3 of the General
Rules and Regulations under the Act. The information
contained in or filed with the form will be made a matter
of the public record in the Commission files.
3.A manually signed copy of the Form and amendments thereto
shall be filed with each national securities exchange on
which any class of securities of the registrant is
registered.
4.Amendments to the notifications must also be filed on
Form 12b-25 but need not restate information that has
been correctly furnished. The Form shall be clearly
identified as an amended notification.
5.Electronic Filers. This form shall not be used by
electronic filers unable to timely file a report solely
due to electronic difficulties. Filers unable to submit
a report within the time period prescribed due to
difficulties in electronic filing should comply with
either Rule 201 or Rule 202 of Regulation S-T (232.201 or
232.202 of this chapter) or apply for an adjustment in
filing date pursuant to Rule 13(b) of Regulation S-T
(232.13(b) of this chapter).
